Cocaine Effects in Humans: Physiology and Behavior - 1

This study has been completed.
Sponsor:
Collaborator:
Columbia University
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000200
First received: September 20, 1999
Last updated: September 10, 2008
Last verified: September 2008
  Purpose

The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users.


Condition Intervention Phase
Cocaine-Related Disorders
Drug: Methadone
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Caregiver)
Primary Purpose: Treatment
Official Title: Cocaine Effects in Humans: Physiology and Behavior

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Interaction of cocaine and meds on cardio [ Time Frame: 3 hr ] [ Designated as safety issue: Yes ]
  • Interaction of cocaine & meds on coc's subjective [ Time Frame: 3 hr ] [ Designated as safety issue: Yes ]
  • Effects of medication on cocaine craving [ Time Frame: 3 hr ] [ Designated as safety issue: No ]

Enrollment: 19
Study Start Date: January 1997
Study Completion Date: January 1998
Primary Completion Date: January 1998 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Methadone
    normal maintenance dose
  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000200

Locations
United States, New York
Columbia University
New York, New York, United States, 10023
Sponsors and Collaborators
Columbia University
Investigators
Principal Investigator: Marian Fischman, Ph.D. Columbia University
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00000200     History of Changes
Other Study ID Numbers: NIDA-03818-1, R01-03818-1
Study First Received: September 20, 1999
Last Updated: September 10, 2008
Health Authority: United States: Federal Government
United States: Food and Drug Administration

Additional relevant MeSH terms:
Cocaine-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Substance-Related Disorders

ClinicalTrials.gov processed this record on October 29, 2014